Troxatyl Clinical Trial Is Halted
| SGX plunges on failed clinical trial MarketWatch - 16 hours ago BOSTON (MarketWatch) — Shares of SGX Pharmaceutical plunged over 40% on Tuesday the day after it said it was discontinuing a key clinical trial for its … |
| SGX Shares Dive on Discontinued Study Houston Chronicle, United States - 16 hours ago NEW YORK — Shares of drug developer SGX Pharmaceuticals Inc. plunged Tuesday on news the company will shelve a clinical trial … |
| SGX Pharmaceuticals Plummets TheStreet.com - 18 hours ago SGX Pharmaceuticals (SGXP – commentary – Cramer’s Take) sank a day after saying it would end a clinical trial of Troxatyl as a third-line treatment for … |
| BIOTECH STOCKS MarketWatch - 20 hours ago BOSTON (MarketWatch) — Benchmarks tracking drug and biotechnology stocks were on the rise Tuesday, but shares of SGX Pharmaceuticals plunged as the sector’s … |
| SGX Pharma Discontinues Troxatyl Trial Houston Chronicle, United States - Aug 28, 2006 SAN DIEGO — SGX Pharmaceuticals Inc. said Monday it discontinued a late stage trial of its lead candidate Troxatyl for certain … |
| UPDATE 1-SGX stops Troxatyl clinical trial, shares tank on Inet Reuters - Aug 28, 2006 Michael Grey, joined us in September 2001 as our Executive Vice President and Chief Business Officer and as a member of our board of directors. He… Full Bio. … |
| SGX Pharmaceuticals Discontinues Phase II/III Clinical Trial of … Yahoo! News (press release) - Aug 28, 2006 SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ — SGX Pharmaceuticals, Inc. (Nasdaq: SGXP – News) announced today that it has discontinued … |
| SGX Stock Plummets After Troxatyl Fails In Phase II/III BioWorld Online, GA - 7 hours ago By Aaron Lorenzo. Shares in SGX Pharmaceuticals Inc. suffered mightily on Tuesday following a Phase II/III study stoppage. An independent … |
| SGX Pharmaceuticals Inc. Fell Below Support On Troxatyl News Trading Markets, CA - 15 hours ago (RTTNews) – SGX Pharmaceuticals Inc. (SGXP | charts | news | PowerRating) announced after the close on Monday that it discontinued … |
| SGX Pharma cancels phase III clinical trial San Diego Daily Transcript (subscription), CA - Aug 28, 2006 By JERAN WITTENSTEIN, The Daily Transcript. San Diego-based SGX Pharmaceuticals Inc. (Nasdaq: SGXP, News) announced Monday it has … |
| SGX Discontinues Phase II/III Clinical Trial Of Troxatyl In Third … Trading Markets, CA - Aug 28, 2006 (RTTNews) – SGX Pharmaceuticals, Inc. (SGXP | charts | news | PowerRating) said Monday that it has discontinued the Phase II/III … |
| SGX Pharmaceuticals Discontinues Phase II/III Clinical Trial Of … Medical News Today (press release), UK - Aug 29, 2006 SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) announced today that it has discontinued the Phase II/III clinical trial of Troxatyl(TM … |
| UPDATE: SGX Plunges On Failed Clinical Trial Easy Bourse (Communiqués de presse), France - 9 hours ago By Val Brickates Kennedy. BOSTON (Dow Jones) — Shares of SGX Pharmaceutical plunged over 40% on Tuesday the day after it said it … |
| SGX Pharmaceuticals Discontinues Phase II/III Clinical Trial of … PipelineReview.com (press release), Spain - Aug 29, 2006 SAN DIEGO, CA, USA | Aug 28, 2006 | SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) announced today that it has discontinued the Phase … |
| SGX Pharmaceuticals Discontinues Phase II/III Clinical Trial of … PharmaLive.com (press release), PA - Aug 28, 2006 SAN DIEGO, August 28, 2006 /PRNewswire-FirstCall/ — SGX Pharmaceuticals, Inc. announced today that it has discontinued the Phase … |
| SGX Pharmaceuticals Discontinues Phase II/III Clinical Trial of … PR Newswire (press release), NY - Aug 28, 2006 Conference Call Scheduled for 6:30 pm EDT today SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ — SGX Pharmaceuticals, Inc. (Nasda |

Add A Comment
You must be logged in to post a comment.